Indeed, blocking mitochondrial transfer from osteocytes to tumor cells—via MIROCKO—blocked an inflammatory cGAS-STING signature in tumor cells and decreased antitumor immune responses (65). The gene discussed is CGAS; the disease is neoplasm.